Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Goodwill: 2019-2025

Historic Goodwill for Lineage Cell Therapeutics (LCTX) over the last 7 years, with Sep 2025 value amounting to $10.7 million.

  • Lineage Cell Therapeutics' Goodwill changed negligibly% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Goodwill of $10.7 million as of Q3 2025, which was down 0.00% from $10.7 million recorded in Q2 2025.
  • Lineage Cell Therapeutics' 5-year Goodwill high stood at $10.7 million for Q1 2021, and its period low was $10.7 million during Q1 2021.
  • For the 3-year period, Lineage Cell Therapeutics' Goodwill averaged around $10.7 million, with its median value being $10.7 million (2025).